Clinical Trial Update: Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal doxorubicin (Lipo-dox) in combination with cyclophosphamide and 5-fluorouracil for metastatic breast cancer; current status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Lipo-dox (liposomal doxorubicin)

Snippet

Sponsor: TTY Biopharm | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN